One carbon metabolic enzyme MTHFD2 is essential for breast cancer metastasis to lung

被引：0
|
作者：
Wang, Yuming [1 ]
Nishimura, Tatsunori [1 ]
Li, Mengjiao [1 ]
Yao, Ryoji [2 ]
Gotoh, Noriko [1 ]
机构：
[1] Kanazawa Univ, Canc Res Ctr, Dept Canc Cell Bil, Kanazawa, Ishikawa, Japan
[2] Japanese Fdn Canc Res, Dept Cell Biol, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1132
引用
收藏
页码：375 / 375
页数：1
相关论文
共 50 条
  • [11] One carbon metabolic enzyme MTHFD1L could be a novel molecular target for breast cancer
    Lee, Jin
    Nishimura, Tatsunori
    Ishikawa, Satoko
    Ohta, Tetsuo
    Tojo, Arinobu
    Gotoh, Noriko
    CANCER SCIENCE, 2021, 112 : 697 - 697
  • [12] Increased MTHFD2 expression is associated with poor prognosis in breast cancer
    Liu, Feng
    Liu, Yang
    He, Chuan
    Tao, Li
    He, Xiaoguang
    Song, Hongtao
    Zhang, Guoqiang
    TUMOR BIOLOGY, 2014, 35 (09) : 8685 - 8690
  • [13] Mitochondrial one-carbon metabolic enzyme MTHFD1L is a novel molecular target for breast cancer
    Kusunoki, Hirokazu
    Hongu, Tsunaki
    Nishimura, Tatsunori
    Takeuchi, Yasuto
    Okamoto, Koji
    Gotoh, Noriko
    CANCER SCIENCE, 2025, 116 : 1749 - 1749
  • [14] Non-metabolic function of MTHFD2 activates CDK2 in bladder cancer
    Liu, Xi
    Liu, Shuangjie
    Piao, Chiyuan
    Zhang, Zhe
    Zhang, Xiaotong
    Jiang, Yuanjun
    Kong, Chuize
    CANCER SCIENCE, 2021, 112 (12) : 4909 - 4919
  • [15] Targeting the one-carbon metabolism protein MTHFD2 for cancer therapy: Exploiting the unique redox status of cancer cells
    Glasauer, Andrea
    Steckel, Michael
    Haegebarth, Andrea
    Bauser, Marcus
    Toschi, Luisella
    CANCER RESEARCH, 2016, 76
  • [16] MTHFD2 facilitates breast cancer cell proliferation via the AKT signaling pathway
    Huang, Jun
    Qin, Yinyin
    Lin, Canfeng
    Huang, Xiaoguang
    Zhang, Feiran
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (01)
  • [17] Impact of MTHFD2 Expression in Bladder/Breast Cancer and Screening of Its Potential Inhibitor
    Aruge, Samreen
    Asif, Maleeha
    Tariq, Aamira
    Asif, Saaim
    Zafar, Muhammad
    Elahi, Muhammad Affan
    Riaz, Lubna
    Javed, Aneela
    Bostan, Nazish
    Sattar, Sadia
    ACS OMEGA, 2024, 9 (44): : 44193 - 44202
  • [18] Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer
    Achreja, Abhinav
    Yu, Tao
    Mittal, Anjali
    Choppara, Srinadh
    Animasahun, Olamide
    Nenwani, Minal
    Wuchu, Fulei
    Meurs, Noah
    Mohan, Aradhana
    Jeon, Jin Heon
    Sarangi, Itisam
    Jayaraman, Anusha
    Owen, Sarah
    Kulkarni, Reva
    Cusato, Michele
    Weinberg, Frank
    Kweon, Hye Kyong
    Subramanian, Chitra
    Wicha, Max S.
    Merajver, Sofia D.
    Nagrath, Sunitha
    Cho, Kathleen R.
    DiFeo, Analisa
    Lu, Xiongbin
    Nagrath, Deepak
    NATURE METABOLISM, 2022, 4 (09) : 1119 - +
  • [19] Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer
    Abhinav Achreja
    Tao Yu
    Anjali Mittal
    Srinadh Choppara
    Olamide Animasahun
    Minal Nenwani
    Fulei Wuchu
    Noah Meurs
    Aradhana Mohan
    Jin Heon Jeon
    Itisam Sarangi
    Anusha Jayaraman
    Sarah Owen
    Reva Kulkarni
    Michele Cusato
    Frank Weinberg
    Hye Kyong Kweon
    Chitra Subramanian
    Max S. Wicha
    Sofia D. Merajver
    Sunitha Nagrath
    Kathleen R. Cho
    Analisa DiFeo
    Xiongbin Lu
    Deepak Nagrath
    Nature Metabolism, 2022, 4 : 1119 - 1137
  • [20] Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
    Zhang, Hao
    Zhu, Shuangli
    Zhou, Haiting
    Li, Rui
    Xia, Xiaohui
    Xiong, Huihua
    FRONTIERS IN ONCOLOGY, 2023, 13
12345